Danaher Co. (NYSE:DHR) shares reached a new 52-week high on Friday . The stock traded as high as $100.39 and last traded at $99.74, with a volume of 1316500 shares. The stock had previously closed at $99.59.
DHR has been the topic of several recent analyst reports. Credit Suisse Group reissued a “hold” rating and set a $99.00 price objective on shares of Danaher in a research note on Tuesday, December 19th. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Robert W. Baird reissued a “buy” rating and set a $99.00 price objective on shares of Danaher in a research note on Friday, December 15th. Morgan Stanley reissued an “overweight” rating and set a $95.00 price objective (up previously from $86.00) on shares of Danaher in a research note on Friday, October 6th. Finally, Cowen reissued a “buy” rating and set a $90.00 price objective on shares of Danaher in a research note on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $94.91.
The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The stock has a market capitalization of $69,780.00, a P/E ratio of 29.68, a price-to-earnings-growth ratio of 2.16 and a beta of 1.03.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date of this dividend is Thursday, December 28th. Danaher’s payout ratio is currently 16.67%.
In other news, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO Robert S. Lutz sold 11,189 shares of the business’s stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the sale, the chief accounting officer now directly owns 18,314 shares in the company, valued at approximately $1,678,661.24. The disclosure for this sale can be found here. In the last ninety days, insiders sold 273,810 shares of company stock worth $25,218,813. Insiders own 12.20% of the company’s stock.
Several hedge funds have recently made changes to their positions in the company. ETRADE Capital Management LLC increased its holdings in Danaher by 5.1% during the second quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock worth $1,610,000 after buying an additional 917 shares during the last quarter. Roundview Capital LLC increased its holdings in Danaher by 2.0% during the second quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock worth $2,167,000 after buying an additional 502 shares during the last quarter. Honeywell International Inc. increased its holdings in Danaher by 113.4% during the third quarter. Honeywell International Inc. now owns 640,100 shares of the conglomerate’s stock worth $54,908,000 after buying an additional 340,100 shares during the last quarter. Veritable L.P. increased its holdings in Danaher by 28.2% during the second quarter. Veritable L.P. now owns 40,486 shares of the conglomerate’s stock worth $3,417,000 after buying an additional 8,912 shares during the last quarter. Finally, Wealthfront Inc. increased its holdings in Danaher by 10.2% during the second quarter. Wealthfront Inc. now owns 14,574 shares of the conglomerate’s stock worth $1,230,000 after buying an additional 1,348 shares during the last quarter. 76.11% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://sportsperspectives.com/2018/01/19/danaher-dhr-sets-new-52-week-high-at-100-39.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.